^
Association details:
Biomarker:No biomarker
Cancer:Peripheral T-cell Lymphoma
Regimen:EPOCH (cyclophosphamide + doxorubicin hydrochloride + etoposide IV + + vincristine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
12/22/2021
Excerpt:
Peripheral T- cell Lymphomas...Other recommended regimens...Dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin)